Funder
National Cancer Institute
U.S. Department of Defense
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS) (2017) National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/
2. Botteri E, Munzone E, Rotmensz N et al (2013) Therapeutic effect of beta-blockers in triple-negative breast cancer in postmenopausal women. Breast Cancer Res Treat 140(3):567–575
3. Melhem-Bertrandt A, Chavez-MacGregor M, Lei X et al (2011) Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol 29(19):2645–2652
4. Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss NS, Li CI (2017) Use of antihypertensive medications and risk of adverse breast cancer outcomes in a SEER-medicare population. Cancer Epidemiol Biomarkers Prev 26(11):1603–1610
5. Boudreau DM, Yu O, Chubak J et al (2014) Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer. Breast Cancer Res Treat 144(2):405–416
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献